Saturday 17 October 2026
Export POM’s income statement to Excel — free account
Pomdoctor Limited - Sponsored ADR
POM Healthcare Pharmaceutical Retailers
Pomdoctor Limited - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $57.2 million, up 21.9% from fiscal 2024.
0.61
0.10
−14.08%
Follow POM
| Dec '24 | Jun '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|
Current Ratio |
0.21 | 0.17 | 0.48 | 0.35 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
Debt/Assets |
947.59% | 1,030.00% | 420.32% | 587.82% |
Debt/Equity |
(0.19) | (0.19) | (0.94) | (0.88) |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | — |
Capex/Depreciation |
(0.25) | 0.00 | (6.73) | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | — |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
(2.21) | (2.09) | (21.38) | — |
Working Capital |
(19.41) | (22.97) | (16.19) | (20.22) |
Capital Expenditures |
0.00 | 0.00 | (0.14) | — |
Net Current Asset Value |
(311.28) | (327.36) | (69.19) | (74.95) |
| Other line items | ||||
Quick Ratio |
0.15 | 0.13 | 0.44 | 0.32 |
Operating CF per Share |
0.00 | 0.00 | 0.00 | — |
Capex per Share |
0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | — |
Columns are period end dates · fundamentals updated 1 Oct 2026